Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOVOCIP: Fosfomycin vs Ciprofloxacin for Febrile Neutropenia Prophylaxis
NCT07616635Phase 3Completed
- Sponsor
- FINBA
- Start
- Mar 2022
- Primary completion
- May 2024
- Countries
- 1
01
Overview
A Phase 3 trial of fosfomycin in febrile neutropenia (FN), sponsored by FINBA. Started Mar 2022; status: completed.
02
Drugs
fosfomycin
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT07616635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07616635.